Showing results (91-100 of 107) with videos related to
Sort By:
Pageof 11
Science Advances|March 29, 2023
Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitorsSeyed Arad Moghadasi, Emmanuel Heilmann, Ahmed Magdy Khalil, et al.Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|December 30, 2022
Does Ultrasound Guidance Provide Pain Relief During Intrauterine Contraceptive Device Insertion? A Systematic Review and Meta-Analysis of Randomized Controlled TrialsSaeed Baradwan, Majed Saeed Alshahrani, Albaraa Alnoury, et al.Therapeutic Advances in Medical Oncology|November 29, 2023
Real-world treatment patterns and clinical outcomes in patients with stage III non-small cell lung cancer: results of KINDLE-Egypt cohortRasha Aboelhassan, Mohamed Emam Sobeih, Mohamed Alm El-Din, et al.International Journal of Surgical Pathology|March 3, 2026
Clinicopathological Predictors of Recurrence in High-Risk Basal Cell Carcinoma Patients, A Retrospective AnalysisNora Abdelhafiz, Abdallah H Mohamed, Mohamed Hussein Mahran, et al.Plos Pathogens|July 21, 2022
Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibodyMichael S Piepenbrink, Jun-Gyu Park, Ashlesha Deshpande, et al.Human Fertility (Cambridge, England)|July 4, 2014
Oral antioxidants supplementation for women with unexplained infertility undergoing ICSI/IVF: randomized controlled trialMohamed A F M Youssef, Hatem I Abdelmoty, Hazem A Elashmwi, et al.European Heart Journal|June 26, 2020
Mapping interventional cardiology in Europe: the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Atlas ProjectEmanuele Barbato, Marko Noc, Andreas Baumbach, et al.Npj Viruses|November 18, 2024
Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variantsMichael S Piepenbrink, Ahmed Magdy Khalil, Ana Chang, et al.Biorxiv : the Preprint Server for Biology|May 15, 2024
Potent neutralization by a receptor binding domain monoclonal antibody with broad specificity for SARS-CoV-2 JN.1 and other variantsMichael S Piepenbrink, Ahmed Magdy Khalil, Ana Chang, et al.Cell Reports. Medicine|January 17, 2026
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoproteinAlexandra A Abu-Shmais, Luqiang Guo, Ahmed Magdy Khalil, et al.Pageof 11